tm
Seeing Is Believing
tm
Seeing Is Believing
AQST is currently covered by 6 analysts with an average price target of $8.75. This is a potential upside of $4.93 (129.06%) from yesterday's end of day stock price of $3.82.
Aquestive Therapeutics's activity chart (see below) currently has 37 price targets and 60 ratings on display. The stock rating distribution of AQST is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 21.3% with an average time for these price targets to be met of 81.63 days.
Highest price target for AQST is $9, Lowest price target is $7, average price target is $8.75.
Most recent stock forecast was given by JASON BUTLER from JMP on 26-Jun-2024. First documented stock forecast 20-Aug-2018.
Currently out of the existing stock ratings of AQST, 26 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
9
$5.8 (181.25%)
8
1 months ago
0/7 (0%)
$6.58 (271.90%)
Buy
9
$5.8 (181.25%)
9
1 months 21 days ago
8/19 (42.11%)
$6.01 (201.00%)
290
Buy
7
$3.8 (118.75%)
10
3 months 28 days ago
0/8 (0%)
$2.74 (64.32%)
Buy
8
$4.8 (150.00%)
4 months 19 days ago
1/5 (20%)
$2.32 (40.85%)
52
Buy
9
$5.8 (181.25%)
4
4 months 19 days ago
5/6 (83.33%)
$3.32 (58.45%)
259
What is AQST (Aquestive Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AQST (Aquestive Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AQST (Aquestive Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?
Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?
Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?
